Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Shota Nakayama, Satoru Yonekura, Saeko Nakajima, Kenji Kabashima
Natura: Artículo Open Access
Pubblicazione: Wiley 2025
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867018294694772736
author Shota Nakayama
Satoru Yonekura
Saeko Nakajima
Kenji Kabashima
author_facet Shota Nakayama
Satoru Yonekura
Saeko Nakajima
Kenji Kabashima
Shota Nakayama
Satoru Yonekura
Saeko Nakajima
Kenji Kabashima
collection Wiley Open Access
contents Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report Shota Nakayama Satoru Yonekura Saeko Nakajima Kenji Kabashima International Journal of Dermatology 10.1111/ijd.17821 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/ijd.17821
format Artículo Open Access
id wiley_oa_10_1111_ijd_17821
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report
Shota Nakayama
Satoru Yonekura
Saeko Nakajima
Kenji Kabashima
International Journal of Dermatology
Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report Shota Nakayama Satoru Yonekura Saeko Nakajima Kenji Kabashima International Journal of Dermatology 10.1111/ijd.17821 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report
topic International Journal of Dermatology
url https://onlinelibrary.wiley.com/doi/10.1111/ijd.17821